Sign inGet started

TZYM

TRANZYME INCCIK 1274644 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
14

AI insights for TZYM PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for TZYM
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
Davidson AaronDirector1$0$02012-08-07
Garg Vipin KPresident & CEO1$0$02012-08-07
Eisenstadt Richard IVP, Finance & CFO1$0$02012-08-07
Castaigne Jean-PaulDirector1$0$02012-08-07
Thomas HelmutSenior VP, R&D1$0$02012-08-07
Zisson AlexDirector1$0$02012-08-07
ABERCROMBIE GEORGE BDirector1$0$02012-08-07
JOHNSON JOHNDirector1$0$02012-08-07
VANLENT ANNEDirector1$0$02012-08-07
ROUSSEAU FRANCKChief Medical Officer2$0$02012-08-07
Moore DavidVP, Commercial Operations1$0$02012-04-19
Baker Biotech Capital (GP), LLC10% Owner7$312.1K$02012-03-14
BAKER FELIX10% Owner7$3.08M$02012-03-14
BAKER JULIAN10% Owner7$81.2K$02012-03-14

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
ABERCROMBIE GEORGE BDirector A Award deriv2012-08-072012-08-0931,835— $031,835SEC↗
JOHNSON JOHNDirector A Award deriv2012-08-072012-08-0921,044— $021,044SEC↗
Zisson AlexDirector A Award deriv2012-08-072012-08-0931,835— $031,835SEC↗
Garg Vipin KPresident & CEO A Award deriv2012-08-072012-08-0950,000— $050,000SEC↗
ROUSSEAU FRANCKChief Medical Officer A Award deriv2012-08-072012-08-098,000— $08,000SEC↗
Castaigne Jean-PaulDirector A Award deriv2012-08-072012-08-0926,448— $026,448SEC↗
VANLENT ANNEDirector A Award deriv2012-08-072012-08-0931,835— $031,835SEC↗
Davidson AaronDirector A Award deriv2012-08-072012-08-0931,835— $031,835SEC↗
Eisenstadt Richard IVP, Finance & CFO A Award deriv2012-08-072012-08-0940,000— $040,000SEC↗
Thomas HelmutSenior VP, R&D A Award deriv2012-08-072012-08-0990,000— $090,000SEC↗
Moore DavidVP, Commercial Operations A Award deriv2012-04-192012-04-2350,000— $050,000SEC↗
ROUSSEAU FRANCKChief Medical Officer A Award deriv2012-04-192012-04-23100,000— $0100,000SEC↗
BAKER JULIAN10% Owner P Buy2012-03-142012-03-141,482$2.99 $4.4K56,794SEC↗
BAKER JULIAN10% Owner P Buy2012-03-142012-03-14910$3.01 $2.7K57,704SEC↗
Baker Biotech Capital (GP), LL10% Owner P Buy2012-03-142012-03-144,592$3.01 $13.8K232,011SEC↗
Baker Biotech Capital (GP), LL10% Owner P Buy2012-03-142012-03-147,484$2.99 $22.4K227,419SEC↗
BAKER FELIX10% Owner P Buy2012-03-142012-03-1456,294$2.99 $168.3K3,505,471SEC↗
BAKER FELIX10% Owner P Buy2012-03-142012-03-1434,544$3.01 $104.0K3,540,015SEC↗
BAKER JULIAN10% Owner P Buy2012-03-132012-03-144,186$2.96 $12.4K55,312SEC↗
Baker Biotech Capital (GP), LL10% Owner P Buy2012-03-132012-03-1415,599$2.96 $46.2K219,935SEC↗
BAKER FELIX10% Owner P Buy2012-03-132012-03-14159,015$2.96 $470.7K3,449,177SEC↗
BAKER JULIAN10% Owner P Buy2012-03-122012-03-1415,076$2.55 $38.4K51,126SEC↗
BAKER JULIAN10% Owner P Buy2012-03-122012-03-148,628$2.34 $20.2K36,050SEC↗
BAKER JULIAN10% Owner P Buy2012-03-122012-03-141,170$1.87 $2.2K27,422SEC↗
BAKER JULIAN10% Owner P Buy2012-03-122012-03-14430$1.89 $81326,252SEC↗
Baker Biotech Capital (GP), LL10% Owner P Buy2012-03-122012-03-141,601$1.89 $3.0K111,631SEC↗
Baker Biotech Capital (GP), LL10% Owner P Buy2012-03-122012-03-144,363$1.87 $8.2K115,994SEC↗
Baker Biotech Capital (GP), LL10% Owner P Buy2012-03-122012-03-1432,155$2.34 $75.2K148,149SEC↗
Baker Biotech Capital (GP), LL10% Owner P Buy2012-03-122012-03-1456,187$2.55 $143.3K204,336SEC↗
BAKER FELIX10% Owner P Buy2012-03-122012-03-14572,737$2.55 $1.46M3,290,162SEC↗
BAKER FELIX10% Owner P Buy2012-03-122012-03-14327,769$2.34 $767.0K2,717,425SEC↗
BAKER FELIX10% Owner P Buy2012-03-122012-03-1444,467$1.87 $83.2K2,389,656SEC↗
BAKER FELIX10% Owner P Buy2012-03-122012-03-1416,326$1.89 $30.9K2,345,189SEC↗